Table 3.

Prerenal transplant clinical and laboratory data in five children with FSGS and podocin mutations

PatientsPalbApo JApo E
SerumAloneSerum + UrineSerum + Normal UrineSerum(μg/ml)Urine(μg/ml)Serum(μg/ml)Urine(μg/ml)
a nd, not detectable.
b P < 0.01 versus normal controls.
NPHS2
10.77 ± 0.010.1 ± 0.030.75 ± 0.020.210.0010.100.0001
20.88 ± 0.040.1 ± 0.010.88 ± 0.010.180.00050.200.00012
30.87 ± 0.080.200.00070.150.0002
40.73 ± 0.020.200.00120.140.00018
50.80 ± 0.040.11 ± 0.020.79 ± 0.020.150.0010.180.0001
Mean ± SD0.81 ± 0.060.07 ± 0.060.80 ± 0.070.19 ± 0.02b0.0009 ± 0.00020.17 ± 0.03b0.0001 ± 0.00004
Controls (20)< 0.2< 0.20.35 ± 0.07nd0.08 ± 0.02a0.0015 ± 0.0001